Silencing LY6K Suppresses CD44+ EpCAM+ HCT116 Human Colon Cancer Stem Cells Growth: Insights from In Vitro and In Vivo EvidenceChanghao Fu(Jilin University), Yi Wang(Jilin University)Current Issues in Molecular BiologyDecember 12, 202410.3390/cimb46120840Cited by 1SaveCiteExport RISWatch citationsRelated PapersPlatelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway|Oncology Reports|2020|48Dendritic cells loaded with CD44+ CT‑26 colon cell lysate evoke potent antitumor immune responses|Oncology Letters|2019|15Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133+ HepG2 liver cancer cells|Oncology Letters|2018|9